MELA Sciences Inc Share Price Nasdaq
Equities
US55277R1005
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
29/04 | STRATA Skin Sciences OKs 1-for-10 Reverse Split | MT |
09/04 | STRATA Skin Sciences, Inc. Announces Renewal of Exclusive Distribution Agreements in China and Japan | CI |
Sales 2024 * | 31.79M 2.65B | Sales 2025 * | 34.77M 2.9B | Capitalization | 13.68M 1.14B |
---|---|---|---|---|---|
Net income 2024 * | -7M -584M | Net income 2025 * | -5M -417M | EV / Sales 2024 * | 0.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.39 x |
P/E ratio 2024 * |
-1.86
x | P/E ratio 2025 * |
-2.69
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.41% |
Latest transcript on MELA Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 10/18/10 |
Director of Finance/CFO | 42 | 06/21/06 | |
Shmuel Gov
COO | Chief Operating Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patricia Walker
BRD | Director/Board Member | 64 | 14/22/14 |
Uri Geiger
CHM | Chairman | 56 | 29/18/29 |
Homi Shamir
BRD | Director/Board Member | 70 | - |
1st Jan change | Capi. | |
---|---|---|
+8.88% | 219B | |
+8.68% | 185B | |
+14.25% | 135B | |
+28.18% | 107B | |
+14.65% | 51.28B | |
+4.48% | 51.01B | |
+4.39% | 41.85B | |
+7.00% | 37.02B | |
+26.06% | 31.27B |